Drug discovery in academia
- 1 August 2015
- journal article
- review article
- Published by Elsevier in Experimental Hematology
- Vol. 43 (8) , 713-717
Abstract
No abstract availableKeywords
Funding Information
- Princess Margaret Cancer Centre Foundation
- Ministry of Long Term Health and Planning
This publication has 20 references indexed in Scilit:
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomideLeukemia, 2012
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomideBlood, 2011
- Bridging the gapmAbs, 2011
- BRAFMutations in Hairy-Cell LeukemiaNew England Journal of Medicine, 2011
- US academic drug discoveryNature Reviews Drug Discovery, 2011
- Traversing the Valley of Death: A Guide to Assessing Prospects for Translational SuccessScience Translational Medicine, 2009
- Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cellsBlood, 2009
- The evolution of thalidomide and its IMiD derivatives as anticancer agentsNature Reviews Cancer, 2004
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999